MS Speaks
Multiple Sclerosis => TREATMENTS => Topic started by: agate on April 10, 2021, 08:45:03 pm
-
From Multiple Sclerosis News Today (April 7, 2021)--"Tecfidera, Gilenya, Ocrevus Losing Favor as Switch Therapies in US, Spherix Finds":
https://multiplesclerosisnewstoday.com/news-posts/2021/04/07/tecfidera-gilenya-ocrevus-losing-ground-ms-dmt-switches-us-spherix-survey/